Organization Overview
Historical Acquisition Tree
Alternative names
Key: Sanofi-Synthelabo (0) Acquired (7)
alfuzosin (uroxatral) (2003 NDA)
doxercalciferol (hectorol) (1999)
fexofenadine (allegra) (2000)
fondaparinux sodium (arixtra) (2001 NDA)
oxaliplatin (eloxatin) (2002 NDA)
rasburicase (Elitek) (2002 NDA)
sarilumab (kevzara) (2017)
Key: Sanofi-Synthelabo (1) Acquired (177)
abiraterone (zytiga) (7 trials)
acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (48 trials)
acetaminophen (tylenol) (11 trials)
acetylsalicylic acid (aspirin) (12 trials)
aciclovir (zovirax) (5 trials)
adefovir dipivoxil (hepsera) (1 trial)
agalsidase alfa (Replagal) (2 trials)
agalsidase beta (Fabrazyme) (4 trials)
alemtuzumab (campath) (5 trials)
alfuzosin (uroxatral) (26 trials)
alglucosidase alfa (myozyme) (4 trials)
alirocumab (praluent) (51 trials)
amisulpride (BARHEMSYS) (9 trials)
amodiaquine (camoquin) (8 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (8 trials)
atenolol (tenormin) (2 trials)
atorvastatin (lipitor) (22 trials)
avalglucosidase alfa (Nexviazyme) (6 trials)
azathioprine (imuran) (1 trial)
azithromycin (zithromax) (9 trials)
Bacterial Lysates (pulmonarom) (1 trial)
benzoyl peroxide (clearasil) (2 trials)
bezafibrate (Bezalip) (2 trials)
bisacodyl (Halflytely) (2 trials)
Bivalent group A and C meningococcal vaccine (Menomune-A/C) (4 trials)
bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (6 trials)
cabazitaxel (jevtana kit) (57 trials)
carboplatin (paraplatin) (53 trials)
cetirizine (zyrtec) (3 trials)
cholera vaccine (Vaxchora) (2 trials)
ciprofloxacin (cipro) (3 trials)
cisplatin (platinol) (70 trials)
clarithromycin (biaxin) (2 trials)
clindamycin (cleocin) (2 trials)
dexchlorpheniramine maleate (polaramine) (3 trials)
diphenhydramine (benadryl) (13 trials)
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (13 trials)
diphtheria, tetanus and whole cell pertussis vaccine (Boostrix) (1 trial)
docetaxel (taxotere) (240 trials)
dronedarone (multaq) (17 trials)
DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine (Pediarix) (16 trials)
dupilumab (dupixent) (89 trials)
enoxaparin (lovenox) (41 trials)
enzalutamide (xtandi) (4 trials)
esomeprazole (nexium) (1 trial)
everolimus (zortress) (1 trial)
felodipine (plendil) (2 trials)
fenofibrate (fenoglide) (8 trials)
fexofenadine (allegra) (20 trials)
Filgrastim (neupogen) (11 trials)
fluorouracil (efudex) (90 trials)
glatiramer acetate (copaxone) (5 trials)
glimepiride (amaryl) (23 trials)
glipizide (glucotrol) (1 trial)
glucagon-like peptide-1 (2 trials)
glyburide (micronase) (3 trials)
granisetron (kytril) (1 trial)
haemophilus influenzae type b conjugate vaccine (HibTITER) (11 trials)
haloperidol (haldol) (1 trial)
heparin (liquaemin) (10 trials)
hepatitis a vaccine, inactivated (vaqta) (8 trials)
hydrochlorothiazide (esidrix) (12 trials)
hydroxychloroquine (plaquenil) (9 trials)
icosapent ethyl (vascepa) (3 trials)
imiglucerase (cerezyme) (3 trials)
inactivated influenza vaccine (88 trials)
insulin aspart (Novolog) (7 trials)
insulin degludec (tresiba) (5 trials)
insulin detemir (Levemir) (5 trials)
insulin human (humulin) (63 trials)
insulin lispro (humalog) (23 trials)
irbesartan (avapro) (37 trials)
ketoprofen (orudis) (5 trials)
Laronidase (Aldurazyme) (1 trial)
leflunomide (arava) (9 trials)
leuprolide (lupron) (7 trials)
levofloxacin (levaquin) (4 trials)
levothyroxine (Synthroid) (3 trials)
liraglutide (victoza) (6 trials)
live attenuated chimeric japanese encephalitis vaccine (9 trials)
live attenuated varicella vaccine (Varivax) (6 trials)
live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin) (1 trial)
lixisenatide (adlyxin) (48 trials)
loratadine (claritin) (3 trials)
lumefantrine (Coartem) (4 trials)
measles, mumps, and rubella vaccine (MMR) (7 trials)
Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (41 trials)
metformin (glucophage) (11 trials)
methylprednisolone (medrol) (7 trials)
metoclopramide (reglan) (1 trial)
metoprolol (lopressor) (4 trials)
metronidazole (flagyl) (1 trial)
montelukast (singulair) (6 trials)
mycophenolate (CellCept) (2 trials)
nateglinide (starlix) (1 trial)
olanzapine (zyprexa) (2 trials)
ondansetron (zofran) (2 trials)
oxaliplatin (eloxatin) (148 trials)
paliperidone (invega) (1 trial)
pioglitazone (actos) (7 trials)
plerixafor (mozobil) (14 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (37 trials)
polio, inactivated poliovirus vaccine (Salk Vaccine) (8 trials)
polyene phosphatidylcholine (1 trial)
potassium iodide (thyro-block) (1 trial)
procaine benzylpenicillin (novocaine) (6 trials)
pseudoephedrine (Benylin) (2 trials)
pyrimethamine (daraprim) (1 trial)
rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (8 trials)
ranitidine (zantac) (12 trials)
rasburicase (Elitek) (13 trials)
repaglinide (prandin) (2 trials)
risedronate (actonel) (31 trials)
risperidone (risperdal) (2 trials)
rosuvastatin (crestor) (15 trials)
sargramostim (leukine) (17 trials)
sarilumab (kevzara) (31 trials)
sitagliptin (januvia) (65 trials)
split virion influenza vaccine (2 trials)
sulfasalazine (azulfidine) (4 trials)
tacrolimus (prograf) (5 trials)
telithromycin (ketek) (21 trials)
tenecteplase (tnkase) (2 trials)
teriflunomide (aubagio) (22 trials)
Tetanus and diphtheria toxoids adsorbed (Decavac) (4 trials)
tirofiban (aggrastat) (1 trial)
tofogliflozin hydrate (2 trials)
triamcinolone (kenalog) (7 trials)
valproic acid (depakene) (7 trials)
vancomycin (Vancocin) (1 trial)
Key: Sanofi-Synthelabo (2) Acquired (197)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (3 trials)
adalimumab (humira) (2 trials)
aflibercept (zaltrap) (40 trials)
albiglutide (tanzeum) (1 trial)
allopurinol (zyloprim) (3 trials)
amiodarone (cordarone) (2 trials)
amlodipine (norvasc) (4 trials)
antihemophilic factor viii (Recombinant) (Adynovate) (2 trials)
anti-inhibitor coagulant complex (activated prothrombin complex concentrate) (Autoplex-T) (1 trial)
antirabies serum (equine) (2 trials)
antithrombin iii (human) (thrombate iii) (2 trials)
avobenzone (shade uvaguard) (2 trials)
belumosudil (Rezurock) (10 trials)
bevacizumab (avastin) (42 trials)
bicalutamide (casodex) (4 trials)
bifidobacterium longum (1 trial)
bivalent subtype c gp120 (1 trial)
bortezomib (velcade) (13 trials)
budesonide (rhinocort) (3 trials)
calcitriol (rocaltrol) (4 trials)
capecitabine (xeloda) (71 trials)
caplacizumab (cablivi) (2 trials)
carfilzomib (kyprolis) (5 trials)
c. difficile toxoid vaccine (2 trials)
cemiplimab (libtayo) (27 trials)
cetuximab (erbitux) (18 trials)
cetylpyridinium chloride (2 trials)
cholestyramine (questran) (7 trials)
ciclesonide (alvesco) (5 trials)
clobetasol (dermovate) (1 trial)
clofarabine (clolar) (2 trials)
coagulation factor ix (Recombinant) (Rixubis) (1 trial)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
cyclophosphamide (cytoxan) (33 trials)
diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (17 trials)
doxercalciferol (hectorol) (2 trials)
doxorubicin (Doxil) (24 trials)
dulaglutide (trulicity) (2 trials)
ecamsule (Mexoryl SX) (2 trials)
eliglustat (cerdelga) (7 trials)
empagliflozin (jardiance) (3 trials)
epirubicin (ellence) (14 trials)
eptifibatide (integrilin) (2 trials)
erlotinib (tarceva) (16 trials)
escitalopram (lexapro) (6 trials)
estramustine (emcyt) (5 trials)
ethambutol (myambutol) (2 trials)
etoposide (vepesid) (7 trials)
fedratinib (Inrebic) (10 trials)
finasteride (Proscar) (1 trial)
fludarabine (fludara) (6 trials)
fluindione (previscan) (1 trial)
fluocinolone acetonide (synalar) (1 trial)
fluticasone (cutivate) (8 trials)
fluvastatin (lescol) (5 trials)
fondaparinux sodium (arixtra) (6 trials)
gemcitabine (gemzar) (61 trials)
goserelin (zoladex) (2 trials)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
hepatitis b vaccine (recombinant) (Recombivax) (7 trials)
hpv 16/18 vaccine (Cervarix) (2 trials)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
human rotavirus, live attenuated (Rotarix) (1 trial)
hydrocortisone (solu-cortef) (1 trial)
inactivated japanese encephalitis vaccine (Ixiaro) (10 trials)
Inactivated polio virus - Enhanced (IPOL) (5 trials)
inactivated rabies vaccine (Imovax) (5 trials)
irinotecan (Camptosar) (42 trials)
Isatuximab (Sarclisa) (46 trials)
isoniazid (nydrazid) (4 trials)
ivermectin (stromectol) (5 trials)
lenalidomide (revlimid) (15 trials)
levocarnitine (carnitor) (1 trial)
live, attenuated, dengue serotype 1, 2, 3, 4 virus (11 trials)
live tetravalent chimeric dengue vaccine (DENGVAXIA) (15 trials)
lovastatin (mevacor) (2 trials)
measles, mumps, rubella, varicella vaccine (ProQuad) (2 trials)
migalastat (galafold) (1 trial)
mitiglinide (Glufast) (1 trial)
mitoxantrone (novantrone) (4 trials)
modafinil (provigil) (1 trial)
mometasone (elocon) (5 trials)
Monovalent group C meningococcal vaccine (Menomune-C) (1 trial)
moxifloxacin (avelox) (1 trial)
naltrexone (revia) (11 trials)
nirsevimab (Beyfortus) (1 trial)
olipudase alfa (Xenpozyme) (4 trials)
omega-3 fatty acids (Omacor) (2 trials)
omeprazole (prilosec) (8 trials)
paclitaxel (taxol) (20 trials)
palbociclib (ibrance) (2 trials)
peginterferon beta-1a (Plegridy) (5 trials)
pembrolizumab (keytruda) (8 trials)
pemetrexed (alimta) (11 trials)
phenprocoumon (liquamar) (1 trial)
phenylephrine (Prefrin) (1 trial)
piperacillin (pipracil) (1 trial)
pitavastatin (livalo) (3 trials)
pneumococcal 7-valent conjugate vaccine (Prevnar) (2 trials)
pomalidomide (pomalyst) (9 trials)
pravastatin (pravachol) (5 trials)
prednisolone (hydeltra) (6 trials)
pyrazinamide (Aldinamide) (2 trials)
rabies immune globulin (human) (HyperRAB) (1 trial)
riferminogene pecaplasmid (6 trials)
rituximab (rituxan) (7 trials)
sars-cov-2 adjuvanted recombinant protein vaccine (bivalent) (1 trial)
sars-cov-2 adjuvanted recombinant protein vaccine (monovalent) (1 trial)
sevelamer (renagel) (5 trials)
simvastatin (zocor) (12 trials)
somatropin (protropin) (3 trials)
sorafenib (nexavar) (4 trials)
sotagliflozin (Inpefa) (23 trials)
sutimlimab (Enjaymo) (1 trial)
tamoxifen (nolvadex) (1 trial)
telmisartan (micardis) (1 trial)
ticlopidine (ticlid) (2 trials)
tocilizumab (actemra) (3 trials)
topotecan (hycamtin) (6 trials)
trastuzumab (herceptin) (23 trials)
typhoid vi polysaccharide vaccine (Typhim Vi) (1 trial)
vinorelbine (navelbine) (14 trials)
warfarin (coumadin) (8 trials)
Key: Sanofi-Synthelabo (0) Acquired (168)
adenosine (Adenocard) (1 trial)
albumin iodinated i-131 serum (Megatope) (1 trial)
albuterol (proventil) (3 trials)
aldesleukin (Proleukin) (5 trials)
alvac melanoma multi-antigen therapeutic vaccine (1 trial)
apalutamide (erleada) (1 trial)
atezolizumab (Tecentriq) (1 trial)
autologous mononuclear stem cell (1 trial)
autologous natural killer cells (1 trial)
belantamab mafodotin (TECVAYLI) (1 trial)
bendamustine (treanda) (2 trials)
betamethasone (celestone) (1 trial)
bivalent cyd-1,3 dengue (1 trial)
bivalent cyd-2,4 dengue (1 trial)
celecoxib (celebrex) (1 trial)
clostridium difficile toxoids a and b (5 trials)
cobimetinib (cotellic) (1 trial)
coltuximab ravtansine (5 trials)
cromoglicic acid (Intal) (1 trial)
cytarabine (cytosar-u) (6 trials)
diethylstilbestrol (Fosfestrol) (1 trial)
donepezil (aricept) (2 trials)
erythromycin (ilosone) (2 trials)
florbetapir (Amyvid) (1 trial)
fludeoxyglucose f-18 (1 trial)
formoterol (foradil) (2 trials)
fulvestrant (faslodex) (2 trials)
gvax prostate cancer vaccine (1 trial)
human choriogonadotropin alfa (hCG) (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
idarubicin (idamycin) (1 trial)
immune globulin (human) (Gamastan) (2 trials)
interferon alpha-2a (roferon-a) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
levalbuterol (xopenex) (3 trials)
levoleucovorin (fusilev) (1 trial)
meningococcal groups a, b, c, w, and Y vaccine (PENBRAYA) (1 trial)
methylphenidate (ritalin) (1 trial)
nolpitantium besylate (1 trial)
octreotide (sandostatin) (1 trial)
pegaspargase (oncaspar) (1 trial)
polymyxin b sulfate (poly-rx) (1 trial)
polysaccharide diphtheria toxoid conjugate vaccine (2 trials)
quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (5 trials)
ramucirumab (cyramza) (2 trials)
recombinant adenoviral human p53 gene (1 trial)
regadenoson (lexiscan) (1 trial)
rifapentine (priftin) (5 trials)
rotavirus vaccine, live, oral, pentavalent (Rotateq) (2 trials)
rubidium chloride rb-82 (1 trial)
serogroup b meningococcal vaccine (Trumenba) (2 trials)
sildenafil (viagra) (2 trials)
smallpox vaccine, heat-stable freeze-dried powder, first generation (3 trials)
smallpox vaccine, lister strain (Dryvax) (1 trial)
smallpox vaccine, tissue culture adapted jennerian (ACAM2000) (2 trials)
sotorasib (LUMAKRAS) (1 trial)
sp0202-vii pneumococcal conjugate vaccine (1 trial)
temozolomide (temodar) (5 trials)
timothy grass pollen allergen extract (Grastek) (1 trial)
tolterodine (detrol) (2 trials)
vincristine (oncovin) (1 trial)
Key: Sanofi-Synthelabo (0) Acquired (64)
acetylcholine chloride (miochol) (1 trial)
alendronic acid (fosamax) (1 trial)
emicizumab (Hemlibra) (1 trial)
itraconazole (sporanox) (1 trial)
keyhole limpet hemocyanin (1 trial)
latanoprost (xalatan) (1 trial)
mefenamic acid (ponstel) (1 trial)
pantoprazole (protonix) (2 trials)
peanut allergen (Palforzia) (1 trial)
pentoxifylline (trental) (1 trial)
pneumococcal protein vaccine (1 trial)
Key: Sanofi-Synthelabo (0) Acquired (27)
Adenocarcinoma (Phase 2)
Adenoma (Phase 3)
Alcohol Drinking (Phase 2)
Aortic Valve Stenosis (Phase 1)
Biliary Tract Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 3)
Constriction, Pathologic (Phase 1)
Coronary Artery Disease (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 3)
Digestive System Diseases (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Diseases (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Heart Failure (Phase 3)
Hyperplasia (Phase 3)
Lung Neoplasms (Phase 2)
Lupus Erythematosus, Systemic (Phase 4)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Malaria (Phase 3)
Malaria, Cerebral (Phase 3)
Mental Disorders (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Neuralgia (Phase 3)
Pancreatic Neoplasms (Phase 2)
Parasomnias (Phase 2)
Prodromal Symptoms (Phase 4)
Prostatic Hyperplasia (Phase 3)
Prostatic Neoplasms (Phase 4)
Psychotic Disorders (Phase 4)
Recurrence (Phase 3)
Salivary Gland Neoplasms (Phase 2)
Schizophrenia (Phase 4)
Sleep Wake Disorders (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 2)
Thrombosis (Phase 4)
Urinary Bladder Neoplasms (Phase 2)